Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study

Veterinarians face the lack of a rapid, reliable, inexpensive, and treatment-sensitive metrological instrument reflecting feline osteoarthritis (OA) pain. The Montreal Instrument for Cat Arthritis Testing, for Use by Veterinarians (MI-CAT(V)) has been refined in 4 sub-sections, and we proposed its c...

Full description

Bibliographic Details
Main Authors: Aliénor Delsart, Colombe Otis, Vivian S. Y. Leung, Émilie Labelle, Maxim Moreau, Marilyn Frezier, Marlene Drag, Johanne Martel-Pelletier, Jean-Pierre Pelletier, Eric Troncy
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/14/5/711
_version_ 1797264949043527680
author Aliénor Delsart
Colombe Otis
Vivian S. Y. Leung
Émilie Labelle
Maxim Moreau
Marilyn Frezier
Marlene Drag
Johanne Martel-Pelletier
Jean-Pierre Pelletier
Eric Troncy
author_facet Aliénor Delsart
Colombe Otis
Vivian S. Y. Leung
Émilie Labelle
Maxim Moreau
Marilyn Frezier
Marlene Drag
Johanne Martel-Pelletier
Jean-Pierre Pelletier
Eric Troncy
author_sort Aliénor Delsart
collection DOAJ
description Veterinarians face the lack of a rapid, reliable, inexpensive, and treatment-sensitive metrological instrument reflecting feline osteoarthritis (OA) pain. The Montreal Instrument for Cat Arthritis Testing, for Use by Veterinarians (MI-CAT(V)) has been refined in 4 sub-sections, and we proposed its concurrent validation. Cats naturally affected by OA (<i>n</i> = 32) were randomly distributed into 4 groups of firocoxib analgesic (Gr. A: 0.40; B: 0.25; C: 0.15, and P: 0.00 mg/kg bodyweight). They were assessed during Baseline, Treatment, and Recovery periods using MI-CAT(V) and objective outcomes (effort path, stairs assay compliance, and actimetry). The MI-CAT(V) total score correlated to the effort path and actimetry (Rho<sub>S</sub> = −0.501 to −0.453; <i>p</i> < 0.001), also being sensitive to treatment responsiveness. The pooled treatment group improved its total, gait, and body posture scores during Treatment compared to the Baseline, Recovery, and placebo group (<i>p</i> < 0.05). The MI-CAT(V) suggested a dose-(especially for Gr. B) and cluster-response. Cats in the moderate and severe MI-CAT(V) clusters responded to firocoxib with a remaining analgesic effect, while the mild cluster seemed less responsive and experienced a negative rebound effect. The MI-CAT(V) was validated for its OA pain severity discriminatory abilities and sensitivity to firocoxib treatment, providing a new perspective for individualized care.
first_indexed 2024-04-25T00:37:01Z
format Article
id doaj.art-e3599958e241467f88782507626b3ee5
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-04-25T00:37:01Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-e3599958e241467f88782507626b3ee52024-03-12T16:38:00ZengMDPI AGAnimals2076-26152024-02-0114571110.3390/ani14050711Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded StudyAliénor Delsart0Colombe Otis1Vivian S. Y. Leung2Émilie Labelle3Maxim Moreau4Marilyn Frezier5Marlene Drag6Johanne Martel-Pelletier7Jean-Pierre Pelletier8Eric Troncy9Groupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Université de Montréal, St-Hyacinthe, QC J2S 2M2, CanadaGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Université de Montréal, St-Hyacinthe, QC J2S 2M2, CanadaGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Université de Montréal, St-Hyacinthe, QC J2S 2M2, CanadaGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Université de Montréal, St-Hyacinthe, QC J2S 2M2, CanadaGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Université de Montréal, St-Hyacinthe, QC J2S 2M2, CanadaGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Université de Montréal, St-Hyacinthe, QC J2S 2M2, CanadaBoehringer Ingelheim Animal Health, Fulton, MO 65251, USAOsteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montreal, QC H2X 0A9, CanadaOsteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montreal, QC H2X 0A9, CanadaGroupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Université de Montréal, St-Hyacinthe, QC J2S 2M2, CanadaVeterinarians face the lack of a rapid, reliable, inexpensive, and treatment-sensitive metrological instrument reflecting feline osteoarthritis (OA) pain. The Montreal Instrument for Cat Arthritis Testing, for Use by Veterinarians (MI-CAT(V)) has been refined in 4 sub-sections, and we proposed its concurrent validation. Cats naturally affected by OA (<i>n</i> = 32) were randomly distributed into 4 groups of firocoxib analgesic (Gr. A: 0.40; B: 0.25; C: 0.15, and P: 0.00 mg/kg bodyweight). They were assessed during Baseline, Treatment, and Recovery periods using MI-CAT(V) and objective outcomes (effort path, stairs assay compliance, and actimetry). The MI-CAT(V) total score correlated to the effort path and actimetry (Rho<sub>S</sub> = −0.501 to −0.453; <i>p</i> < 0.001), also being sensitive to treatment responsiveness. The pooled treatment group improved its total, gait, and body posture scores during Treatment compared to the Baseline, Recovery, and placebo group (<i>p</i> < 0.05). The MI-CAT(V) suggested a dose-(especially for Gr. B) and cluster-response. Cats in the moderate and severe MI-CAT(V) clusters responded to firocoxib with a remaining analgesic effect, while the mild cluster seemed less responsive and experienced a negative rebound effect. The MI-CAT(V) was validated for its OA pain severity discriminatory abilities and sensitivity to firocoxib treatment, providing a new perspective for individualized care.https://www.mdpi.com/2076-2615/14/5/711felineosteoarthritisfirocoxibpain scalemetrologyactimetry
spellingShingle Aliénor Delsart
Colombe Otis
Vivian S. Y. Leung
Émilie Labelle
Maxim Moreau
Marilyn Frezier
Marlene Drag
Johanne Martel-Pelletier
Jean-Pierre Pelletier
Eric Troncy
Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study
Animals
feline
osteoarthritis
firocoxib
pain scale
metrology
actimetry
title Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study
title_full Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study
title_fullStr Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study
title_full_unstemmed Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study
title_short Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study
title_sort concurrent validation of mi cat v a clinical metrology instrument for veterinarians assessing osteoarthritis pain in cats through testing for firocoxib analgesic efficacy in a prospective randomized controlled and blinded study
topic feline
osteoarthritis
firocoxib
pain scale
metrology
actimetry
url https://www.mdpi.com/2076-2615/14/5/711
work_keys_str_mv AT alienordelsart concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT colombeotis concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT viviansyleung concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT emilielabelle concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT maximmoreau concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT marilynfrezier concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT marlenedrag concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT johannemartelpelletier concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT jeanpierrepelletier concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy
AT erictroncy concurrentvalidationofmicatvaclinicalmetrologyinstrumentforveterinariansassessingosteoarthritispainincatsthroughtestingforfirocoxibanalgesicefficacyinaprospectiverandomizedcontrolledandblindedstudy